Cofactor Joins FNIH Biomarkers Consortium to Add Predictive Immune Modeling Expertise as New Resource for Multidimensional Biomarker Discovery
San Francisco, June 4, 2019 --Cofactor Genomics, pioneers in the field of Predictive Immune Modeling, announced today that they have become a member of the Foundation for the National Institutes of Health (FNIH) Biomarkers Consortium with the goal of advancing the adoption of ...
Cofactor Genomics to provide solid tumor immune profiling for Genocea Biosciences
San Francisco, December 4, 2018 -- Cofactor Genomics, a clinical RNA sequencing and translational assay developer, today announced a pilot study to evaluate use of Cofactor’s ImmunoPrismTM assay in Genocea Biosciences’ Phase 1/2a clinical trial testing the safety and efficacy ...
Cofactor Genomics Launches ImmunoPrism Immune Profiling Kit, for Use in Clinical Sequencing Laboratories
San Francisco, October 30, 2018 -- Cofactor Genomics, a clinical RNA sequencing and translational assay developer, announced today the launch of a RNA-based immune profiling kit developed for laboratories wishing to derive the immune composition of tumor samples. The tumor’s i...